Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial

Your email address will not be published. Required fields are marked *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Comment